企業プロフィール
Mersana Therapeutics 株価・ニュース・カタリスト
- ティッカー:
- MRSN
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価変動の要因
Current closing-price context is not available for MRSN.
企業概要
事業概要
Mersana Therapeutics is an oncology company developing antibody-drug conjugates for cancer. The company’s identity is built around payload delivery and targeted tumor therapy.
所在地とセクター分類
Headquartered in the United States and listed on NASDAQ, Mersana sits in oncology biotechnology.
ビジネスモデルの特徴
Its business depends on clinical data, platform differentiation, and the ability to turn ADC science into a commercial story.
バイオ業界での位置付け
Mersana is a classic ADC catalyst name where efficacy and tolerability can quickly change sentiment.
今後のカタリスト
- Mersana's catalysts are its ADC programs, especially XMT-1660 and XMT-2056, where any clean data can change the tone quickly. The company is still very much a data story.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。